Spray Drying Biotherapeutics Dry powder formulations of Biotherapeutics eliminate the need for expensive cold chain storage and facilitate supply chain management. Lyophilisation is traditionally used for the drying process, but in recent years the semi-continuous, robust and scalable qualities of spray drying have made it the drying process of choice. With expert formulation and process … Read more
Non-GMP Pilot Plant Extended Capabilities Upperton Pharma Solutions now has a fully commissioned 60 square metre non-GMP pilot plant, mirroring our GMP manufacturing facility. The pilot plant is equipped for three scales of spray drying: ProCept 4M8-Trix for batch sizes of up to 300g Upperton Intermediate Spray Dryer for batch sizes of up to 1kg GEA … Read more
22nd January 2019 – Successful completion of EU Horizon 2020 Grant MACIVIVA In 2014, Upperton Pharma Solutions was awarded a prestigious Horizon 2020 MACIVIVA grant as part of a European consortium led by Mymetics, a pioneering company at the forefront of the development of virosome-based vaccines. The MACIVIVA goal was to develop dry powder, thermostable, cold-chain … Read more
8th January 2019 – Press Release Upperton Pharma Solutions’ new pharmaceutical spray drying manufacturing facilities at Nottingham Science and Technology Park have successfully passed inspection by the UK Medicines and Healthcare products Regulatory Agency (MHRA). A pharmaceutical spray drying contract development and manufacturing organisation (CDMO), Upperton Pharma Solutions moved to its new facilities on Nottingham … Read more
Driven by experts, led by science
Integrated CDMO services
Events
Development Platforms
Route of delivery
By Development Stage
About Us
Our Approach
Resources
Policies
Trent Gateway, Technology Drive, Beeston, Nottingham, NG9 1LA, UK. Phone: +44 (0) 115 855 7050 Email: contact@upperton.com
Copyright © 2024 Upperton Limited. All rights reserved.
Speak with our team of experts and set up a discovery call to discuss your project in more detail.